Pacira BioSciences PCRX
NASDAQ PCRX
$25.05 -0.60 (-2.34%)
At close: Sep 30, 2026 · 4:00 PM EDT

Pacira BioSciences (PCRX) Operating Income (2010 - 2026)

Updated

Pacira BioSciences (PCRX) reported Operating Income of $4.27 million for Q2 2026, down 49.8% from $8.5 million a year earlier and down 38.2% from the prior quarter.

Analysis

Pacira BioSciences (PCRX) Operating Income (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Pacira BioSciences' Operating Income came in at $19.87 million; for FY2025, it came in at $19.19 million.

  • Operating Income has a five-year compound annual growth rate of -16.2% (FY2020 to FY2025).
  • By year, Operating Income came in at -$73.37 million in FY2024, $87.68 million in FY2023 (+46.1%), $60.02 million in FY2022 (-33.3%) and $89.92 million in FY2021 (+94.0%).
  • Five-year quarterly Operating Income spans a low of -$139.53 million in Q3 2024 and a high of $39.88 million in Q2 2023.
  • Year over year, Operating Income gained in 1 of the last six quarters, with an average decline of 12.3%.
  • The high point for year-over-year Operating Income in five years was Q1 2026 (growth of 246.8%); the low point was Q4 2025 (a decline of 90.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $6.9 million (Q1 2026), $2.34 million (Q4 2025) and $6.36 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 7.14 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 6.43 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.75 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 3.16 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 3.51 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.39 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.27 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Pacira BioSciences 997.55 Mn 59.58 Mn 148.24 Mn 4.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.27 Mn
Mar 31, 2026 6.90 Mn
Dec 31, 2025 2.34 Mn
Sep 30, 2025 6.36 Mn
Jun 30, 2025 8.50 Mn
Mar 31, 2025 1.99 Mn
Dec 31, 2024 24.70 Mn
Sep 30, 2024 -139.53 Mn
Jun 30, 2024 28.24 Mn
Mar 31, 2024 13.21 Mn
Dec 31, 2023 33.17 Mn
Sep 30, 2023 17.72 Mn
Jun 30, 2023 39.88 Mn
Mar 31, 2023 -3.09 Mn
Dec 31, 2022 -9.89 Mn
Sep 30, 2022 21.29 Mn
Jun 30, 2022 31.24 Mn
Mar 31, 2022 17.39 Mn
Dec 31, 2021 4.21 Mn
Sep 30, 2021 31.43 Mn
API Access

Pacira BioSciences Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=PCRX&period=max&api_key=YOUR_API_KEY